MarketPeel
Insider Trading Intelligence
RH

Rekha Hemrajani

LBRX
DIRECTOR · LB PHARMACEUTICALS INC · CIK 0001771213
FILING MIX · LIFETIME96%/4%
BUYS
25
SELLS
1
TOTAL VALUE
$179.8K
COMPANIES
4
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
121,979
AVG SELL PX
$2.09
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Rekha Hemrajani, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+2.77%+0.88%+1.89%+3.44%
14d3+33.33%-1.00%+1.58%-2.58%-1.89%
30d3+66.67%+5.52%+1.33%+4.18%+3.18%
60d3+33.33%-18.64%+3.65%-22.29%-12.08%
90d3+33.33%-44.42%+3.95%-48.38%-34.99%
180d3+33.33%-59.54%+3.73%-63.27%-68.99%
1y3+33.33%-49.74%+16.98%-66.72%-68.08%
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LBRX · 10,000 shares · as of Jun 3, 2026
05,61211,22516,83722,4492026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 1 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
49,57949,579Jun 17, 2026Jun 22, 2026View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
30,42170,314Jun 17, 2026Jun 22, 2026View →
BIOA
BIOAGE LABS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jun 10, 2026Jun 12, 2026View →
LBRX
LB PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,00010,000Jun 3, 2026Jun 5, 2026View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
40,40040,400Jan 20, 2026Jan 21, 2026View →
LBRX
LB PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,44922,449Sep 10, 2025Sep 12, 2025View →
MXCT
MAXCYTE, INC.
SALE10b5-1
10b5-1 plan
10,684$2.09$22.4K39,893Jun 25, 2025Aug 27, 2025View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
29,21050,577Jun 18, 2025Jun 23, 2025View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
50,79050,790Jun 18, 2025Jun 23, 2025View →
BIOA
BIOAGE LABS, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jun 5, 2025Jun 9, 2025View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
40,40040,400Jan 21, 2025Jan 23, 2025View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
30,000$1.55$46.4K33,000Dec 2, 2024Dec 4, 2024View →
BIOA
BIOAGE LABS, INC.
PURCHASE
3,000$18.00$54.0K3,000Sep 27, 2024Mar 10, 2025View →
BIOA
BIOAGE LABS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Sep 25, 2024Sep 27, 2024View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
20,20020,200Jun 13, 2024Jun 14, 2024View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
40,70140,701Jun 11, 2024Jun 13, 2024View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
21,36721,367Jun 11, 2024Jun 13, 2024View →
BIOA
BIOAGE LABS, INC.
PURCHASEGRANT
Stock grant
28,49728,497Apr 17, 2024Sep 27, 2024View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 22, 2023Jun 23, 2023View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
20,20020,200Jun 20, 2023Jun 22, 2023View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
40,00040,000Mar 20, 2023Mar 21, 2023View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
26,90026,900Jun 29, 2022Jul 8, 2022View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
12,00412,004Jun 15, 2022Jun 16, 2022View →
MXCT
MAXCYTE, INC.
PURCHASEGRANT
Stock grant
10,00010,000Aug 9, 2021Aug 11, 2021View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASEGRANT
Stock grant
12,00412,004Jun 11, 2021Jun 15, 2021View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
3,000$19.00$57.0K3,000Jul 21, 2020Jul 21, 2020View →
Other insiders · LBRX
Loading peer insiders…
About this filer
CIK 0001771213
ROLE
Director
PRIMARY
LBRX
COMPANIES
4
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001771213DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback